The significance of paracardiac lymph-node enlargement in patients with newly diagnosed stage IIIC ovarian cancer

Gynecologic Oncology

Volumn 138, Issue 2, 2015, Pages 259-262

  Raban, Oded ^a,b   Peled, Yoav ^a,b   Krissi, Haim ^a,b   Goldberg, Natalia ^a,b   Aviram, Amir ^a,b   Sabah, Gad ^a,b   Levavi, Hanoch ^a,b   Eitan, Ram ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Metastasis; Ovarian carcinoma; Survival

Indexed keywords

CA 125 ANTIGEN;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; ASCITES; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE FREE INTERVAL; DISEASE FREE SURVIVAL; FEMALE; HISTOLOGY; HUMAN; LYMPHADENOPATHY; MULTIMODALITY CANCER THERAPY; OVARY CARCINOMA; OVERALL SURVIVAL; PARACARDIAC LYMPHADENOPATHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT RESPONSE; LYMPH NODE; LYMPH NODE METASTASIS; METASTASIS; MIDDLE AGED; NEOPLASM; OVARY TUMOR; PATHOLOGY;

AGED; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 84938207881     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2015.05.007     Document Type: Article

References (23)

1. R.E. Bristow, L.R. Duska, N.C. Lambrou, E.K. Fishman, M.J. O'Neill, E.L. Trimble, and et al. A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography Cancer 89 2000 1532 1540 10.1002/1097-0142(20001001)89:7<1532::AID-CNCR17>3.0.CO;2-A
2. R. Forstner, E. Sala, K. Kinkel, and J.A. Spencer ESUR guidelines: Ovarian cancer staging and follow-up Eur. Radiol. 20 2010 2773 2780 10.1007/s00330-010-1886-4
3. D.G. Mitchell, M.C. Javitt, P. Glanc, G.L. Bennett, D.L. Brown, T. Dubinsky, and et al. ACR appropriateness criteria staging and follow-up of ovarian cancer J. Am. Coll. Radiol. 10 2013 822 827 10.1016/j.jacr.2013.07.017
4. J. Dauplat, N.F. Hacker, R.K. Nieberg, J.S. Berek, T.P. Rose, and S. Sagae Distant metastases in epithelial ovarian carcinoma Cancer 60 1987 1561 1566
5. H. Bonnefoi, R.P. A'Hern, C. Fisher, V. Macfarlane, D. Barton, P. Blake, and et al. Natural history of stage IV epithelial ovarian cancer 17 1999
6. H. Rouviere Anatomie des lymphatics de l'Homme 1932 Masson Paris
7. R.A. Castellino, and N. Blank Adenopathy of the cardiophrenic angle (diaphragmatic) lymph nodes Am. J. Roentgenol. Radium Ther. Nucl. Med. 114 1972 509 515
8. G.B. Feldman Lymphatic obstruction in carcinomatous ascites Cancer Res. 35 1975 325 332
9. M.F. Abu-Hijleh, O.A. Habbal, and S.T. Moqattash The role of the diaphragm in lymphatic absorption from the peritoneal cavity J. Anat. 186 Pt 3 1995 453 467
10. J. Prat Staging classification for cancer of the ovary, fallopian tube, and peritoneum Int. J. Gynaecol. Obstet. 124 2014 1 5 10.1016/j.ijgo.2013.10.001
11. FIGO staging classifications and clinical practice gudelines in the management of gynecologic cancers Int. J. Gynecol. Obstet. 70 2000 209 262 10.1016/S0020-7292(00)90001-8
12. G.J.S. Rustin, I. Vergote, E. Eisenhauer, E. Pujade-Lauraine, M. Quinn, T. Thigpen, and et al. Definitions for response and progression in ovarian cancer clinical trials incorporating RECIST 1.1 and CA 125 agreed by the Gynecological Cancer Intergroup (GCIG) Int. J. Gynecol. Cancer 21 2011 419 423 10.1097/IGC.0b013e3182070f17
13. B.J. Holloway, M.E. Gore, R.P. A'Hern, and C. Parsons The significance of paracardiac lymph node enlargement in ovarian cancer Clin. Radiol. 52 1997 692 697 10.1016/S0009-9260(97)80034-7
14. V. Kolev, S. Mironov, O. Mironov, N. Ishill, C.S. Moskowitz, G.J. Gardner, and et al. Prognostic significance of supradiaphragmatic lymphadenopathy identified on preoperative computed tomography scan in patients undergoing primary cytoreduction for advanced epithelial ovarian cancer Int. J. Gynecol. Cancer 20 2010 979 984 10.1111/IGC.0b013e3181e833f5
15. J. Hynninen, A. Auranen, O. Carpén, K. Dean, M. Seppänen, J. Kemppainen, and et al. FDG PET/CT in staging of advanced epithelial ovarian cancer: frequency of supradiaphragmatic lymph node metastasis challenges the traditional pattern of disease spread Gynecol. Oncol. 126 2012 64 68 10.1016/j.ygyno.2012.04.023
16. E.A. Eisenhauer, P. Therasse, J. Bogaerts, L.H. Schwartz, D. Sargent, R. Ford, and et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) Eur. J. Cancer 45 2009 228 247 10.1016/j.ejca.2008.10.026
17. J. Hynninen, J. Kemppainen, M. Lavonius, J. Virtanen, J. Matomäki, S. Oksa, and et al. A prospective comparison of integrated FDG-PET/contrast-enhanced CT and contrast-enhanced CT for pretreatment imaging of advanced epithelial ovarian cancer Gynecol. Oncol. 131 2013 389 394 10.1016/j.ygyno.2013.08.023
18. K. Kitajima, K. Murakami, S. Sakamoto, Y. Kaji, and K. Sugimura Present and future of FDG-PET/CT in ovarian cancer Ann. Nucl. Med. 25 2011 155 164 10.1007/s12149-010-0449-8
19. S. Risum, C. Høgdall, A. Loft, A.K. Berthelsen, E. Høgdall, L. Nedergaard, and et al. Does the use of diagnostic PET/CT cause stage migration in patients with primary advanced ovarian cancer? Gynecol. Oncol. 116 2010 395 398 10.1016/j.ygyno.2009.12.008
20. Y. Yuan, Z.-X. Gu, X.-F. Tao, and S.-Y. Liu Computer tomography, magnetic resonance imaging, and positron emission tomography or positron emission tomography/computer tomography for detection of metastatic lymph nodes in patients with ovarian cancer: a meta-analysis Eur. J. Radiol. 81 2012 1002 1006 10.1016/j.ejrad.2011.01.112
21. M.C. Lim, H.-S. Lee, D.C. Jung, J.Y. Choi, S.-S. Seo, and S.-Y. Park Pathological diagnosis and cytoreduction of cardiophrenic lymph node and pleural metastasis in ovarian cancer patients using video-assisted thoracic surgery Ann. Surg. Oncol. 16 2009 1990 1996 10.1245/s10434-009-0486-5
22. H.J. Yoo, M.C. Lim, Y.J. Song, Y.-S. Jung, S.H. Kim, C.W. Yoo, and et al. Transabdominal cardiophrenic lymph node dissection (CPLND) via incised diaphragm replace conventional video-assisted thoracic surgery for cytoreductive surgery in advanced ovarian cancer Gynecol. Oncol. 129 2013 341 345 10.1016/j.ygyno.2012.12.023
23. I. Vergote, C.G. Tropé, F. Amant, G.B. Kristensen, T. Ehlen, N. Johnson, and et al. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer N. Engl. J. Med. 363 2010 943 953 10.1056/NEJMoa0908806